The potential epidemiological impact of a genital herpes vaccine for women. - Wikidata - awgldk - TriplyDB

The potential epidemiological impact of a genital herpes vaccine for women.

The potential epidemiological impact of a genital herpes vaccine for women.

http://www.wikidata.org/entity/Q35562998

about

Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown HSV-2: in pursuit of a vaccine An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection Varicella zoster vaccines and their implications for development of HSV vaccines Prevalence of herpes simplex virus type 2 and risk factors associated with this infection in women in southern Brazil.Current status and prospects for development of an HSV vaccine Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.Epidemiological impact of a genital herpes type 2 vaccine for young females.Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.Glycoprotein D adjuvant herpes simplex virus vaccine.Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs Estradiol improves genital herpes vaccine efficacy in mice.Herpes simplex virus infection in the Croatian population.Seroprevalence of herpes simplex 1-2 antibodies in Brazil.HSV-2 and Substance Abuse amongst Adolescents: Insights through Mathematical Modelling

P2860

Q21296712-4404AE04-7A22-49BD-9754-C4B88ED080A6 Q22306291-70B8E970-E789-49C9-B0A5-3A1CE5827127 Q24646809-3487A38D-7D72-4BAD-B9F5-4B7F425CE3CF Q28280820-60491BF4-DC6B-4AB5-9A66-843606978224 Q33926451-053FF998-1DBE-4D5B-9E19-6752471CE7FB Q33931016-596C40F3-2BBA-429E-87A3-863271FDFE0B Q34380787-BB16A5EF-72B6-458B-B835-C9A21A547CB5 Q34446935-03B36E2A-5985-4A6A-B7A5-37688678FC1A Q35101552-81CC5C26-A9FA-4270-9186-AA7C4A4C0545 Q36284536-F11266D3-19E8-46F7-B346-2CA446FD13F7 Q37201714-06E38DA8-8EF5-44BF-AAB1-4AF5E5AB0BB8 Q37253436-50F7CAF0-2643-47DB-BCCF-35B8DA1E2D06 Q37305719-7BF1A5DA-C8AF-4EA8-ADDB-4DF62A0F1060 Q37359132-D75EE082-7CE5-4A25-8987-9BBB0768BED4 Q39988169-440DEBB4-2BB2-44E0-A0E4-073282FCD0D9 Q44584810-DF3B9A87-143E-4643-B037-D8BA8443FEB1 Q59049355-DA711DD9-F99D-4F18-823C-56F64BA24083

P2860

The potential epidemiological impact of a genital herpes vaccine for women.

http://www.wikidata.org/entity/Q35562998

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

The potential epidemiological impact of a genital herpes vaccine for women.

@ast

The potential epidemiological impact of a genital herpes vaccine for women.

@en

type

label

The potential epidemiological impact of a genital herpes vaccine for women.

@ast

The potential epidemiological impact of a genital herpes vaccine for women.

@en

prefLabel

The potential epidemiological impact of a genital herpes vaccine for women.

@ast

The potential epidemiological impact of a genital herpes vaccine for women.

@en

P1433

Q35562998-CD32AF70-F034-4AC0-8D10-57B146703884

P1476

Q35562998-B03B382B-144F-47C0-A30B-20D34DFD3F6F

P2093

Q35562998-53FB39B0-074A-4973-8B2B-3C9B9086CB94

Q35562998-6E9E612E-AB73-45A3-817E-45F15AB170DF

Q35562998-6FFE7AB2-0E22-452B-8D96-AA10A2B69A43

Q35562998-CCE727EA-D57F-415B-A289-43F915C14927

P2860

Q35562998-193B3C70-F0EC-446A-B017-47DEA9AB146D

Q35562998-4285E239-1509-4A4B-A4F3-DFA4C3BC6C7A

Q35562998-47D2D1BB-AE99-436D-BF99-AC5ADCA73018

Q35562998-4CA3B85D-7E30-449A-90FC-B0A1DA28105D

Q35562998-58276586-B21E-4C33-BADA-B154B7627122

Q35562998-5E3291BF-4731-4289-BF9F-20D3A7244523

Q35562998-810F8710-DF9D-4182-93C0-38E492B1DDA5

Q35562998-9E7DE0C5-7B2C-4E90-A4AD-68472C915B40

Q35562998-B23A2B3F-FEFA-451F-B8A1-6FCD43181F10

Q35562998-BE5CBA19-351C-48E6-89E4-29B88910AE22

P304

Q35562998-905BF17D-634B-46AF-8F4A-D8170F40BC7F

P31

Q35562998-53B139DF-CC1C-44BD-B78B-F0863EC322F8

Q35562998-b0c2d05b-bad3-4121-b397-253b71772019

P356

Q35562998-3540044A-6662-4A29-811D-8E51CDBD5E11

P433

Q35562998-A329326F-1CB0-41B8-8C42-86511FA3BB57

P478

Q35562998-01DFC656-839D-4605-8B06-07DE00F92BA5

P577

Q35562998-C53C72AA-02BA-4668-90BB-C107E72C5D69

P5875

Q35562998-5EDC6D8B-EDD4-44A5-B9D2-10DE16017304

P698

Q35562998-51E6DE4E-3F91-459C-909F-C61C9D79FA33

P921

Q35562998-39A090E9-3A28-4170-9672-36086E636DEA

P932

Q35562998-D21574E0-03ED-4DD6-8E7A-A9A3A169CFEF

P356

STI.2002.003848

P1433

Sexually Transmitted Infections

P1476

The potential epidemiological impact of a genital herpes vaccine for women.

@en

P2093

Darcis T

http://www.w3.org/2001/XMLSchema#string

Dubin G

http://www.w3.org/2001/XMLSchema#string

Garnett GP

http://www.w3.org/2001/XMLSchema#string

Slaoui M

http://www.w3.org/2001/XMLSchema#string

P2860

Risk Factors for the Sexual Transmission of Genital Herpes

Mathematical models of the transmission and control of sexually transmitted diseases.

The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey.

Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease.

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Measuring the risk of HIV transmission.

Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts.

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

P304

24-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/STI.2002.003848

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8892966

http://www.w3.org/2001/XMLSchema#string

P698

14755031

http://www.w3.org/2001/XMLSchema#string

P921

P932

1758372

http://www.w3.org/2001/XMLSchema#string